Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 7265131 Isoquinolinone derivatives and their use as therapeutic agents

Patent 7265131 was granted and assigned to Exelixis on September, 2007 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

All edits

Edits on 30 Oct, 2024

"update inverses"

Golden AI

edited on 30 Oct, 2024

Edits made to:

Infobox (+1 properties)

Infobox

Patent Citations Received

‌

US Patent 12128109 Muscle targeting complexes and formulations for treating dystrophinopathies

Edits on 2 Oct, 2024

"update inverses"

Golden AI

edited on 2 Oct, 2024

Edits made to:

Infobox (+1 properties)

Infobox

Patent Citations Received

‌

US Patent 12102687 Muscle targeting complexes and uses thereof for treating myotonic dystrophy

Edits on 27 Jun, 2024

"update inverses"

Golden AI

edited on 27 Jun, 2024

Edits made to:

Infobox (+1 properties)

Infobox

Patent Citations Received

‌

US Patent 12018087 Muscle-targeting complexes comprising an anti-transferrin receptor antibody linked to an oligonucleotide and methods of delivering oligonucleotide to a subject

Edits on 19 Jun, 2024

"update inverses"

Golden AI

edited on 19 Jun, 2024

Edits made to:

Infobox (+1 properties)

Infobox

Patent Citations Received

‌

US Patent 12012460 Muscle-targeting complexes comprising an anti-transferrin receptor antibody linked to an oligonucleotide

Edits on 12 Jun, 2024

"update inverses"

Golden AI

edited on 12 Jun, 2024

Edits made to:

Infobox (+1 properties)

Infobox

Patent Citations Received

‌

US Patent 12005124 Muscle targeting complexes and uses thereof for treating dystrophinopathies

Edits on 22 May, 2024

"update inverses"

Golden AI

edited on 22 May, 2024

Edits made to:

Infobox (+1 properties)

Infobox

Patent Citations Received

‌

US Patent 11986537 Muscle targeting complexes and uses thereof for treating dystrophinopathies

Edits on 1 May, 2024

"update inverses"

Golden AI

edited on 1 May, 2024

Edits made to:

Infobox (+1 properties)

Infobox

Patent Citations Received

‌

US Patent 11969475 Muscle targeting complexes and uses thereof for treating facioscapulohumeral muscular dystrophy

Edits on 4 Apr, 2024

"update inverses"

Golden AI

edited on 4 Apr, 2024

Edits made to:

Infobox (+1 properties)

Infobox

Patent Citations Received

‌

US Patent 11944631 Combination therapies

Edits on 29 Mar, 2024

"update inverses"

Golden AI

edited on 29 Mar, 2024

Edits made to:

Infobox (+1 properties)

Infobox

Patent Citations Received

‌

US Patent 11939333 Solid forms of isoquinolinones, and process of making, composition comprising, and methods of using the same

Edits on 21 Mar, 2024

"update inverses"

Golden AI

edited on 21 Mar, 2024

Edits made to:

Infobox (+1 properties)

Infobox

Patent Citations Received

‌

US Patent 11931421 Muscle targeting complexes and formulations for treating myotonic dystrophy

Edits on 2 Mar, 2024

"update inverses"

Golden AI

edited on 2 Mar, 2024

Edits made to:

Infobox (+1 properties)

Infobox

Patent Citations Received

‌

US Patent 11911484 Muscle targeting complexes and uses thereof for treating myotonic dystrophy

Edits on 13 Dec, 2023

"update inverses"

Golden AI

edited on 13 Dec, 2023

Edits made to:

Infobox (+1 properties)

Infobox

Patent Citations Received

‌

US Patent 11839660 Anti-transferrin receptor antibody and uses thereof

Edits on 7 Dec, 2023

"update inverses"

Golden AI

edited on 7 Dec, 2023

Edits made to:

Infobox (+1 properties)

Infobox

Patent Citations Received

‌

US Patent 11833217 Muscle targeting complexes and uses thereof for treating dystrophinopathies

Edits on 19 Oct, 2023

"update inverses"

Golden AI

edited on 19 Oct, 2023

Edits made to:

Infobox (+1 properties)

Infobox

Patent Citations Received

‌

US Patent 11787869 Methods of using muscle targeting complexes to deliver an oligonucleotide to a subject having facioscapulohumeral muscular dystrophy or a disease associated with muscle weakness

Edits on 4 Oct, 2023

"update inverses"

Golden AI

edited on 4 Oct, 2023

Edits made to:

Infobox (+1 properties)

Infobox

Patent Citations Received

‌

US Patent 11771776 Muscle targeting complexes and uses thereof for treating dystrophinopathies

Edits on 20 Sep, 2023

"update inverses"

Golden AI

edited on 20 Sep, 2023

Edits made to:

Infobox (+1 properties)

Infobox

Patent Citations Received

‌

US Patent 11759525 Muscle targeting complexes and uses thereof for treating facioscapulohumeral muscular dystrophy

Edits on 1 Sep, 2023

"Add patent abstract"

Golden AI

edited on 1 Sep, 2023

Edits made to:

Article (+40 characters)

Article

Patent abstract

Compounds of formula (I):

Edits on 13 Jul, 2023

"Remove leading 0 from patent number"

Golden AI

edited on 13 Jul, 2023

Edits made to:

Infobox (+1/-1 properties)

‌

US Patent 07265131 Isoquinolinone derivatives and their use as therapeutic agents US Patent 7265131 Isoquinolinone derivatives and their use as therapeutic agents

Infobox

Patent Number

0726513100

Patent Number

726513100

Edits on 20 May, 2023

"Remove website redirecting to Patent Public Search front page"

Golden AI

edited on 20 May, 2023

Edits made to:

Infobox (-1 properties)

Infobox

Official Website

https://pdfpiw.uspto.gov/.piw?Docid=0726513100

Edits on 26 Mar, 2023

"Entity importer update"

Golden AI

edited on 26 Mar, 2023

Infobox

Is a

Patent

Current Assignee

Exelixis

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

072651310

Date of Patent

September 4, 2007

Patent Application Number

107389640

Date Filed

December 17, 2003

Official Website

https://pdfpiw.uspto.gov/.piw?Docid=072651310

Patent Primary Examiner

‌

Zinna N. Davis

Find more entities like US Patent 7265131 Isoquinolinone derivatives and their use as therapeutic agents

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API